SCHEMBL8285273

SCHEMBL8285273

COC(=O)/C=C/c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MLYCD O95822 2/20 0.36
GSK3B P49841 4/20 0.34
NFE2L2 Q16236 1/20 0.34
EGFR P00533 1/20 0.34
BTK Q06187 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
MAPT P10636 2/20 0.33
CSF1R P07333 1/20 0.33
IP6K1 Q92551 1/20 0.33
IP6K3 Q96PC2 1/20 0.33
IP6K2 Q9UHH9 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
MAPK8 P45983 3/20 0.32
MAPK9 P45984 1/20 0.32
GSK3A P49840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287440 0.90 GSK3B (0.36) KDM4ESMN1; SMN2GSK3BEGFRBTK
SCHEMBL8287196 0.82 GSK3B (0.37) KDM4EKMT2ASMN1; SMN2GSK3BEGFR
SCHEMBL8287117 0.80 KDM4E (0.46) KDM4EKMT2ASMN1; SMN2MLYCDGSK3B
SCHEMBL8287576 0.79 GSK3B (0.39) KMT2AGSK3BEGFRMAPTALDH1A1
SCHEMBL8287201 0.78 GSK3B (0.34) KDM4EKMT2AGSK3BEGFRBTK
SCHEMBL8285289 0.78 CCNC (0.37) KDM4EKMT2ASMN1; SMN2MLYCDGSK3B
SCHEMBL8286468 0.78 GSK3B (0.38) KDM4EKMT2ASMN1; SMN2GSK3BEGFR
SCHEMBL8287593 0.78 GSK3B (0.37) KMT2ASMN1; SMN2GSK3BEGFRBTK
SCHEMBL5872050 0.78 GAA (0.44) KMT2ASMN1; SMN2GSK3BMAPTALDH1A1
SCHEMBL8287912 0.77 TSHR (0.38) KDM4EKMT2ASMN1; SMN2GSK3BSIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed